Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Nov 16, 2020 · 10-Q · 47 days after period end · 0001493152-20-021528
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$425.55K | -$1.49M | -$2.12M | -$1.92M |
| EPS Diluted | -$0.71 | -$1.41 | -$10.00 | -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 16, 2020 · 47 d after period end
